Zydus Group clinches in-licensing deal with Swiss co Neovii to market Grafalon drug

Grafalon offers a specific advantage of efficacy and better safety profile through targeted immunosuppression

PTI October 06, 2016 15:46:20 IST
Zydus Group clinches in-licensing deal with Swiss co Neovii to market Grafalon drug

New Delhi: Ahmedabad-based Zydus Group has got into an in-licensing agreement with Switzerland-based Neovii to launch Grafalon, an immunosuppressant used in solid organ transplants and stem cell transplant, in India.

Zydus Group clinches inlicensing deal with Swiss co Neovii to market Grafalon drug

Reuters

"The Zydus group will market this therapy through Zydus Trans-immune, a division that offers a range of therapies related to transplant medicine," group firm Cadila Healthcare said in a filing to BSE.

Grafalon offers a specific advantage of efficacy and better safety profile through targeted immunosuppression, it added.

"More than 200,000 patients till date, in over 50 countries, have been treated with Grafalon," Cadila Healthcare said. Transplant outcomes can be improved significantly by the use of immunosuppressant drugs like Grafalon, it added.

"Currently, an estimated 10,000 solid organ transplant and stem cell transplants are taking place annually across 200 plus transplant centres in India," the company said.

The stock of Cadila Healthcare was today trading at Rs 386.50 in the afternoon trade on BSE, down 0.54 per cent from its previous close.

Updated Date:

also read

Market Roundup: Sensex crashes by over 1,500 points; Nifty at 17,149; check top winners and losers here
Business

Market Roundup: Sensex crashes by over 1,500 points; Nifty at 17,149; check top winners and losers here

Both Sensex and Nifty crashed over 2.5 percent at the end of the trading session, while Sensex fell 2.62 percent to 57,491.51, Nifty slumped 2.66 percent to 17,149.10

Market Roundup: Sensex falls by 427 points, Nifty ends at 17,617; today's top winners and losers
Business

Market Roundup: Sensex falls by 427 points, Nifty ends at 17,617; today's top winners and losers

The top gainers of BSE Sensex were Hindustan Unilever, Maruti, HDFC, Nestle India and HDFC Bank. The top losers were Bajaj Financial Services, Tech Mahindra, Tata Steel, Bharti Airtel and IndusInd Bank

Market Roundup : Sensex falls 634 points, Nifty ends at 17,757; check top winners and losers here
Business

Market Roundup : Sensex falls 634 points, Nifty ends at 17,757; check top winners and losers here

The top gainers were Power Grid, Bharti Airtel, Asian Paints, Maruti and UltraTech Cement. The top losers were Bajaj Financial Services, Infosys, Tata Consultancy Services, Sun Pharma and Hindustan Unilever